ADXN.SW

Addex Therapeutics Ltd
SwissCHFEQUITY Healthcare DELAYED
Last price
0.03
▼ 0.01 (16.91%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.04
Prev close
0.04
Day high
0.07
Day low
0.03
Volume
15.29M
Market cap
$5.32M
P/E (TTM)
52W range
0.03 – 0.09

Day trading desk

Current session · delayed
Gap from prior close
0.00%
Prior close 0.04
VWAP
0.04
-23.23% from price
Relative volume
105.80×
Unusually busy
Session range
122.58%
0.03 – 0.07
Position in range
9%
Near session low
ATR (14D)
0.00
14.37% of price
Prior day high
0.04
PDH
Prior day low
0.04
PDL
Bid / ask spread
Quote not published
Session volume
38.78M
Avg 366.56K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-10.71% -9.3%
1M
-16.67% -20.4%
3M
-26.16% -29.3%
6M
-27.39% -38.5%
YTD
-36.82% -49.1%
1Y
-40.07% -60.1%
3Y
-62.20% -136.4%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on ADXN.SW open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
11.93M
Total on file

Fundamentals

TTM · reported
Market cap$5.32M
Enterprise value$3.34M
Revenue (TTM)$109.50K
Gross profit$-442.22K
EBITDA$-2.69M
Net income$-7.08M
EPS (TTM)$-0.06
Free cash flow$-1.52M
Total cash$935.15K
Total debt$102.27K
Book value / share$0.03
Shares outstanding151.90M
Float97.06M
Short % of float
Dividend yield
Beta (5Y)2.00

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E-0.88
PEG ratio
Price / sales
Price / book1.25
EV / revenue30.53
EV / EBITDA-1.24
Gross margin0.00%
Operating margin-6238.81%
Profit margin0.00%
Return on equity-122.28%
Return on assets-23.59%
Debt / equity3.11
Current ratio0.97
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $29.97K$404.10K$1.61M$1.42M -92.6%
Operating revenue $29.97K$404.10K$1.61M$1.42M -92.6%
Research & development $190.19K$435.19K$942.71K$7.88M -56.3%
Selling, general & admin $1.89M$1.68M$2.03M$3.26M +12.7%
Total operating expense $2.84M$3.16M$3.86M$11.96M -10.0%
Operating income -$2.81M-$2.76M-$2.24M-$10.54M -2.2%
Net interest income -$2.42K$5.62K$60.10K$1.30K -143.1%
Pre-tax income -$6.84M-$4.91M-$2.50M-$10.80M -39.4%
Tax provision $0$0$0$0
Net income -$6.73M$7.06M-$10.56M-$20.80M -195.4%
Net income to common -$6.73M$7.06M-$10.56M-$20.80M -195.4%
Basic EPS -0.060.07-0.14-0.46 -185.7%
Diluted EPS -0.060.07-0.14-0.46 -185.7%
EBIT -$6.84M-$4.91M-$2.50M-$10.78M -39.4%
EBITDA -$6.83M-$4.65M-$2.19M-$10.45M -47.1%
Basic shares 107.37M98.11M74.31M45.18M +9.4%
Diluted shares 107.37M98.11M74.31M82.24M +9.4%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Dec 2024 -0.01-0.01 0.0%
Sep 2024 -0.01-0.02 -100.0%
Jun 2024 -0.01-0.01 0.0%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year $0
Next year $0

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders10.00%
Held by institutions1.02%
Institutions holding8
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.04
-13.96% from price
SMA 20
0.04
-13.04% from price
SMA 50
0.04
-15.91% from price
SMA 100
0.04
-21.34% from price
SMA 200
0.05
-26.90% from price
EMA 12
0.04
-13.61% from price
EMA 26
0.04
-15.09% from price
EMA 50
0.04
-17.22% from price
RSI (14)
37.3
Neutral
MACD (12,26,9)
-0.00
Hist -0.00
ATR (14)
0.00
14.12% of price
Realised vol 30D
81.0%
Annualised
Bollinger upper
0.04
20, 2σ
Bollinger lower
0.04
20, 2σ
50 / 200 cross
Death
0.04 vs 0.05
Trend bias
Below 200
-26.90%

Options chain

Account required
ExpirySpot 0.03
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.11
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
81.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-49.9%
Peak to trough
Max drawdown 5Y
-97.8%
Peak to trough
ATR 14
0.00
14.12% of price
Beta (reported)
2.00
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.